Scientists produce human intestinal lining that re-creates living tissue inside organ-chip

February 16, 2018, The Yates Network
Cells of a human intestinal lining, after being placed in an Intestine-Chip, form intestinal folds as they do in the human body. Credit: Cedars-Sinai Board of Governors Regenerative Medicine Institute

Investigators have demonstrated how cells of a human intestinal lining created outside an individual's body mirror living tissue when placed inside microengineered Intestine-Chips, opening the door to personalized testing of drug treatments.

The findings have the potential to change how patients are treated for debilitating, inflammatory gastrointestinal diseases with a genetic component, such as Crohn's disease, ulcerative colitis and irritable bowel syndrome.

Instead of exposing a patient to drug treatments that may be costly, ineffective or carry harmful side effects, scientists could use the individual's own stem cells to produce a duplicate of the intestinal lining on an Intestine-Chip and test multiple drugs on it. Scientists then could determine which drug worked best on that patient's intestine.

The study was conducted by investigators at the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Emulate, Inc. in Boston.

This advance will allow biomedical scientists to study the functioning of an individual's intestinal lining in a controlled microenvironment, where the lining can interact with , and drugs, said Robert Barrett, PhD, assistant professor of Medicine and research scientist at the Cedars-Sinai Board of Governors Regenerative Medicine Institute. Barrett is senior author of the study, published in Cellular and Molecular Gastroenterology and Hepatology, a journal of the American Gastroenterology Association.

"This pairing of biology and engineering allows us to re-create an intestinal lining that matches that of a patient with a specific intestinal disease-without performing invasive surgery to obtain a tissue sample," said Clive Svendsen, PhD, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and a co-author of the study. "We can produce an unlimited number of copies of this tissue and use them to evaluate potential therapies. This is an important advance in personalized medicine."

Video captures 3-D views of cells of a human intestinal lining after they were placed in an Intestine-Chip, where they formed intestinal folds as they do in the human body. Credit: Cedars-Sinai Board of Governors Regenerative Medicine Institute

The study team used two advanced technologies to produce and sustain the intestinal lining: Cedars-Sinai provided the induced , or iPSCs, while Emulate supplied its Intestine-Chip, which is made out of a flexible polymer that features tiny channels that can be lined with thousands of living human cells.

To make the iPSCs, Cedars-Sinai investigators first took small samples of blood and from an adult. They reprogrammed these cells into iPSCs, which are similar to and can produce any type of body cell. Using special proteins and other substances, the scientists prodded the iPSCs to produce cells of the intestinal lining. Each cell bore the unique genetic fingerprint and characteristics of the adult who donated the original cells. The new cells were used to grow miniature versions of the person's intestine lining, known as organoids.

Microengineered Organ-Chip is made out of a flexible polymer that features tiny channels that can be lined with thousands of living human cells. Credit: Emulate, Inc.

The team then selected cells from these organoids and placed them inside the Intestine-Chips, which are about the size of AA batteries and re-create the natural microenvironment of the human intestine, including the intestinal epithelium-the layer of cells that forms the lining of both the small and large intestines. Fluids were passed through microchannels of these chips, creating an environment that enabled the cells to develop the 3-D villi-like structures as found in the intestine in the body. Tests showed that the intestinal lining the researchers formed contained all the key cell types normally found in such a tissue.

"Organ-Chips address major challenges in studying the human intestine and intestinal diseases in the lab," said Geraldine A. Hamilton, PhD, president and chief scientific officer of Emulate and a co-author of the study. "The Intestine-Chip is a 'home-away-from-home' for human cells, and provides them with the right microenvironment and biological cues they need to behave just like they do in the body. Our Intestine-Chip also allows researchers to culture alongside other cell types, such as immune , and analyze how these different cell types interact.

These miniature versions of a human intestinal lining, known as organoids, were generated using the science of induced pluriportent stem cells, or iPSCs, at Cedars-Sinai. Each cell of the organoids bore the unique genetic fingerprint and characteristics of an individual. Credit: Cedars-Sinai Board of Governors Regenerative Medicine Institute

"Further, by partnering with Cedars-Sinai to generate intestinal linings from iPSCs, we can match the Intestine-Chip to individual donors," Hamilton added.

The study was part of is an initiative of Cedars-Sinai Precision Health, whose goal is to drive the development of the newest technology and best research, coupled with the finest clinical practice, to rapidly enable a new era of personalized health.

Explore further: Team creates functional, stem-cell-derived small bowel segments

More information: Michael J. Workman et al, Enhanced Utilization of Induced Pluripotent Stem Cell–Derived Human Intestinal Organoids Using Microengineered Chips, Cellular and Molecular Gastroenterology and Hepatology (2017). DOI: 10.1016/j.jcmgh.2017.12.008

Related Stories

Team creates functional, stem-cell-derived small bowel segments

October 10, 2017
Using human induced pluripotent stem cells (iPSCs), a Massachusetts General Hospital research team has bioengineered functional small intestine segments that, when implanted into rats, were capable of deliver nutrients into ...

Immune cells surveil intestine to prevent infections

January 4, 2018
As essential as food is for the body to work, its movement through the intestine poses an infection risk. A single layer of cells is tasked with a big responsibility: to keep harmful bacteria out while also maintaining friendly ...

Controlling cell turnover in the intestinal lining

April 5, 2016
The lining of the intestine is the most rapidly-renewing tissue in the body. Routine shedding of epithelial cells from this lining is a key element of tissue turnover, and is thus essential to maintaining optimal health. ...

Molecule plays dual role in bowel health and disease

November 30, 2017
A molecule that controls intestinal cell growth plays a dual role maintaining gut health and promoting diseases such as cancer, says a study in eLife.

Recommended for you

Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning

March 21, 2018
A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal ...

Cold can activate body's 'good' fat at a cellular level, study finds

March 21, 2018
Lower temperatures can activate the body's 'good' fat formation at a cellular level, a new study led by academics at The University of Nottingham has found.

Immune cells in the retina can spontaneously regenerate

March 21, 2018
Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute (NEI). The cells also re-establish ...

Switch discovered to convert blood vessels to blood stem cells in embryonic development

March 20, 2018
A switch has been discovered that instructs blood vessel cells to become blood stem cells during embryonic development in mice. Using single-cell technology, researchers from the Wellcome Sanger Institute in Cambridge and ...

Stem cells treat macular degeneration

March 19, 2018
In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.

Don't blame adolescent social behavior on hormones

March 19, 2018
Reproductive hormones that develop during puberty are not responsible for changes in social behavior that occur during adolescence, according to the results of a newly published study by a University at Buffalo researcher.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.